The registration of over 40 general sales products has been successfully completed. Additionally, various core categories of hospital products, including anti-cancer, antibiotics, antifungals, and mucolytics, have been registered on a fast-track basis. This ensures that essential medications are readily available to healthcare providers and patients.
Efforts have been made to streamline the regulatory process by preparing electronic Common Technical Document (eCTD) submissions for products, making it easier for manufacturers to comply with regulatory requirements. Finely curated regulatory plans are developed based on the product type and its specific documentation, ensuring a smooth and efficient approval process.
Moreover, the preparation of artworks and the renewal of registrations are managed meticulously. Comprehensive scientific literature is prepared for the market launch of new products, providing healthcare professionals with the necessary information to make informed decisions about their use.